RianCorp markets a Low Level Laser Therapy (LLLT) product indicated for the treatment of Lympedema and musculoskeletal pain.  

RianCorp is a small single technology company which would have had  difficulty supporting the quality and regulatory overhead required for the manufacture of this product.  Through our Manufacture By Agreement model, Ingeneus provided a solution for RianCorp’s manufacturing, logistics, service and post market surveillance for their LTU-904 model products.

LLLT uses a laser to bring about a photochemical reaction at a cellular level. The laser light penetrates into tissue where it is absorbed by cells and converted into energy that influences the course of metabolic processes.